{"AllianceGenome": "48925", "HGNC": "48925", "MIM": "615594", "_id": "100506013", "_version": 1, "accession": {"genomic": ["AC104620.5", "AC106872.5", "CP068274.2", "NC_000004.12", "NC_060928.1"], "protein": ["AHW47894.1", "NP_001284479.1", "P0DMC3.1", "XP_016863112.1", "XP_054204663.1"], "rna": ["AK092578.1", "EF565119.1", "KJ158076.1", "NM_001297550.2", "NR_038825.1", "XM_017007623.2", "XM_054348688.1"], "translation": [{"protein": "AHW47894.1", "rna": "KJ158076.1"}, {"protein": "XP_054204663.1", "rna": "XM_054348688.1"}, {"protein": "NP_001284479.1", "rna": "NM_001297550.2"}, {"protein": "XP_016863112.1", "rna": "XM_017007623.2"}]}, "alias": ["ELA", "Ende", "tdl"], "ensembl": {"gene": "ENSG00000248329", "protein": ["ENSP00000478306", "ENSP00000480045", "ENSP00000484618"], "transcript": ["ENST00000505269", "ENST00000507152", "ENST00000510062", "ENST00000515275", "ENST00000515405"], "translation": [{"protein": "ENSP00000484618", "rna": "ENST00000507152"}, {"protein": "ENSP00000480045", "rna": "ENST00000515275"}, {"protein": "ENSP00000478306", "rna": "ENST00000510062"}], "type_of_gene": "protein_coding"}, "entrezgene": "100506013", "exons": [{"cdsend": 164879008, "cdsstart": 164877331, "chr": "4", "position": [[164877177, 164877407], [164878919, 164879009], [164895415, 164897527]], "strand": 1, "transcript": "NM_001297550", "txend": 164897527, "txstart": 164877177}], "exons_hg19": [{"cdsend": 165800160, "cdsstart": 165798483, "chr": "4", "position": [[165798329, 165798559], [165800071, 165800161], [165816567, 165818679]], "strand": 1, "transcript": "NM_001297550", "txend": 165818679, "txstart": 165798329}], "generif": [{"pubmed": 28137936, "text": "These results show ELA exhibits a cardiovascular profile comparable to apelin, is down-regulated in human disease and rodent Pulmonary Arterial Hypertension (PAH) models and that exogenous peptide can reduce the severity of cardiopulmonary remodeling and function in PAH in rats. This study provides additional proof of principle that an apelin receptor agonist may be of therapeutic use for PAH in man."}, {"pubmed": 28371822, "text": "The ELA-APJ axis protects from pressure overload-induced heart failure possibly via suppression of ACE expression and pathogenic angiotensin II signaling."}, {"pubmed": 29036564, "text": "Studies indicate that the Elabela-APJ (apelin receptor) axis may protect against pressure overload-induced heart failure."}, {"pubmed": 29079036, "text": "Disruption of APELA expression in OCCC cell lines suppressed cell growth and migration, and altered cell-cycle progression."}, {"pubmed": 29694663, "text": "ELA has an angiogenetic role in the progression of glial tumors"}, {"pubmed": 30048993, "text": "The results showed that the serum ELA levels decreased gradually with the deterioration of diabetic kidney disease from the stages of normal albuminuria, microalbuminuria, macroalbuminuria, to macroalbuminuria and elevated serum creatinine."}, {"pubmed": 30070701, "text": "Given the role of apelin/APJ and Elabela/APJ in cardiovascular and other diseases, we believe that the combination of these agonists and antagonists with apelin and Elabela will play a corresponding role in various pathophysiological effects with further development of research."}, {"pubmed": 30267732, "text": "The properties and biological functions of ELABELA are discussed in comparison with those of Apelin. (REVIEW)"}, {"pubmed": 30576665, "text": "No significant difference was found in plasma ELABELA levels in pregnant women who developed preeclampsia versus those who did not."}, {"pubmed": 30719741, "text": "Variants in the 5'-UTR of APELA gene may account for variability of APELA expression among individuals with preeclampsia (PE) and may play a negative regulatory role in the pathogenesis of PE."}, {"pubmed": 30860880, "text": "This study identified ELA as significantly decreased in late-onset preeclampsia. An in vitro study showed that the addition of ELA significantly increased the invasion ability and proliferation of trophoblast cells."}, {"pubmed": 31025171, "text": "Apela Promotes Cardiomyocyte Differentiation from Transgenic Human Embryonic Stem Cell Lines."}, {"pubmed": 31064239, "text": "decreased in maternal and cord blood in pre-eclampsia, relative to controls"}, {"pubmed": 31546152, "text": "Reduced ELABELA expression attenuates trophoblast invasion through the PI3K/AKT/mTOR pathway in early onset preeclampsia."}, {"pubmed": 31836787, "text": "Peptide hormone ELABELA enhances extravillous trophoblast differentiation, but placenta is not the major source of circulating ELABELA in pregnancy."}, {"pubmed": 32208782, "text": "Circulating levels of Elabela and Apelin in the second and third trimesters of pregnancies with gestational diabetes mellitus."}, {"pubmed": 32301550, "text": "Elabela/Toddler and apelin bind differently to the apelin receptor."}, {"pubmed": 32516140, "text": "ELA/APELA precursor cleaved by furin displays tumor suppressor function in renal cell carcinoma through mTORC1 activation."}, {"pubmed": 32713880, "text": "Serum Elabela Levels Are Elevated in Patients with Hyperthyroidism."}, {"pubmed": 33062670, "text": "Association between ELABELA Serum Concentrations in First Trimester and Pregnancy-Induced Hypertension."}, {"pubmed": 33163050, "text": "Elabela levels in patients with type 2 diabetes: can it be a marker for diabetic nephropathy?"}, {"pubmed": 34090960, "text": "Elabela/toddler: New peptide with a promising future in cancer diagnostic and therapy."}, {"pubmed": 34276017, "text": "Plasma Level of Elabela in Patients with Coronary Heart Disease and Its Correlation with the Disease Classification."}, {"pubmed": 35630008, "text": "A Case-Control Study of the APELA Gene and Hypertensive Disorders of Pregnancy."}, {"pubmed": 36669444, "text": "Reduced Apela/APJ system expression in patients with pulmonary artery hypertension secondary to chronic obstructive pulmonary disease."}, {"pubmed": 36825397, "text": "Betatrophin, elabela, asprosin, glucagon and subfatin peptides in breast tissue, blood and milk in gestational diabetes."}, {"pubmed": 37062502, "text": "Apelin/ELABELA-APJ system in cardiac hypertrophy: Regulatory mechanisms and therapeutic potential."}, {"pubmed": 37562237, "text": "Therapeutic potential of apelin and Elabela in cardiovascular disease."}], "genomic_pos": {"chr": "4", "end": 164898965, "ensemblgene": "ENSG00000248329", "start": 164877178, "strand": 1}, "genomic_pos_hg19": {"chr": "4", "end": 165820117, "start": 165798156, "strand": 1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0001525", "qualifier": "involved_in", "term": "angiogenesis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0001570", "qualifier": "involved_in", "term": "vasculogenesis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0007492", "qualifier": "involved_in", "term": "endoderm development"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0007507", "qualifier": "involved_in", "term": "heart development"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0007509", "qualifier": "involved_in", "term": "mesoderm migration involved in gastrulation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0007512", "qualifier": "involved_in", "term": "adult heart development"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0035050", "qualifier": "involved_in", "term": "embryonic heart tube development"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0045766", "pubmed": 25639753, "qualifier": "involved_in", "term": "positive regulation of angiogenesis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0045823", "qualifier": "involved_in", "term": "positive regulation of heart contraction"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0060183", "pubmed": 25639753, "qualifier": "involved_in", "term": "apelin receptor signaling pathway"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0060183", "pubmed": 28137936, "qualifier": "involved_in", "term": "apelin receptor signaling pathway"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0060183", "qualifier": "involved_in", "term": "apelin receptor signaling pathway"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0060674", "qualifier": "involved_in", "term": "placenta blood vessel development"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0060976", "qualifier": "involved_in", "term": "coronary vasculature development"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0070374", "qualifier": "involved_in", "term": "positive regulation of ERK1 and ERK2 cascade"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0090133", "qualifier": "involved_in", "term": "mesendoderm migration"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0090134", "qualifier": "involved_in", "term": "cell migration involved in mesendoderm migration"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:1901165", "pubmed": 28663440, "qualifier": "involved_in", "term": "positive regulation of trophoblast cell migration"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:1903589", "qualifier": "involved_in", "term": "positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:1904022", "pubmed": 25639753, "qualifier": "involved_in", "term": "positive regulation of G protein-coupled receptor internalization"}], "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0005576", "pubmed": [24316148, 28137936], "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0005615", "qualifier": "located_in", "term": "extracellular space"}], "MF": [{"category": "MF", "evidence": "IMP", "id": "GO:0005179", "pubmed": [25639753, 28137936], "qualifier": "enables", "term": "hormone activity"}, {"category": "MF", "evidence": "ISS", "id": "GO:0005179", "qualifier": "enables", "term": "hormone activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0031704", "pubmed": 28137936, "qualifier": "enables", "term": "apelin receptor binding"}, {"category": "MF", "evidence": "ISS", "id": "GO:0031704", "qualifier": "enables", "term": "apelin receptor binding"}]}, "interpro": {"desc": "Apelin receptor early endogenous ligand", "id": "IPR047853", "short_desc": "ELA"}, "map_location": "4q32.3", "name": "apelin receptor early endogenous ligand", "other_names": ["apelin receptor early endogenous ligand", "protein Elabela", "protein Toddler"], "pdb": ["7W0N", "7W0O", "7W0P"], "pharmgkb": "PA166123664", "pharos": {"target_id": 6840, "tdl": "Tbio"}, "refseq": {"genomic": ["NC_000004.12", "NC_060928.1"], "protein": ["NP_001284479.1", "XP_016863112.1", "XP_054204663.1"], "rna": ["NM_001297550.2", "NR_038825.1", "XM_017007623.2", "XM_054348688.1"], "translation": [{"protein": "XP_016863112.1", "rna": "XM_017007623.2"}, {"protein": "XP_054204663.1", "rna": "XM_054348688.1"}, {"protein": "NP_001284479.1", "rna": "NM_001297550.2"}]}, "reporter": {"HG-U133_Plus_2": "1559280_a_at", "HTA-2_0": ["TC04000823.hg.1", "TC04002304.hg.1"], "HuEx-1_0": "2750430", "HuGene-2_1": ["16972108", "17123600"]}, "summary": "This gene encodes a peptide hormone that binds to the Apelin receptor. The encoded protein is required for heart development in zebrafish and has been shown to maintain self-renewal of human embryonic stem cells through activation of the PI3K/AKT pathway. Experiments in human and mouse cell lines point to additional roles for the encoded protein in angiogenesis and regulation of vascular tone. [provided by RefSeq, Jul 2016].", "symbol": "APELA", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C3810054"}, "unigene": "Hs.105196", "uniprot": {"Swiss-Prot": "P0DMC3", "TrEMBL": "X5D2P3"}}